Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Gilead Sciences    GILD

GILEAD SCIENCES

(GILD)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Gilead Sciences
Gilead Sciences specializes in the development, manufacturing and marketing of therapeutic products. Net sales break down by source of income as follows:

- sale of drugs (98%): for the treatment of HIV, hepatitis B virus and hepatitis C virus (98.5% of net sales) and other (1.5%; primarily cytomegalovirus retinitis, and advanced Kaposi sarcoma resulting from HIV);

- other (2%): especially royalties and revenue from research and development services and from subcontracted production of therapeutic products.

Net sales are distributed geographically as follows: the United States (73.5%), Europe (18.1%) and other (8.4%).
Sales per Businesses
20162017Delta
USD (in Million)%USD (in Million)%
Innovative Medicines30,390100.2%26,10799.9% -14.09%
Sales per Regions
20162017Delta
USD (in Million)%USD (in Million)%
United States19,35463.8%18,19469.6% -5.99%
Europe6,36521%5,31120.3% -16.56%
Japan2,5278.3%---
Other Countries2,1447.1%2,60210% +21.36%
Managers
NameAgeSinceTitle
Gregg Alton521999Chief Executive & Patient Officer
John Martin671990Chairman
Robin L. Washington MBA, CPA572008CFO, Principal Accounting Officer & Executive VP
John G. McHutchison, MD-2010Chief Scientific Officer
George Pratt Shultz, PhD961996Director-Emeritus
Gayle Edlund Wilson762001Independent Director
John Francis Cogan, PhD712005Lead Independent Director
Richard J. Whitley, MD732008Independent Director
Kevin E. Lofton642009Independent Director
Per Wold-Olsen712010Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Stock A 1 1,266,455,481 1,258,698,353 99.4% 0 0.0% 99.4%
Shareholders
NameEquities%
The Vanguard Group, Inc. 95,194,616 7.36%
Capital Research & Management Co. (Global Investors) 69,854,968 5.40%
BlackRock Fund Advisors 66,448,018 5.14%
SSgA Funds Management, Inc. 56,015,307 4.33%
Fidelity Management & Research Co. 17,555,088 1.36%
Northern Trust Investments, Inc.(Investment Management) 16,606,713 1.28%
Dodge & Cox 16,450,181 1.27%
Geode Capital Management LLC 16,031,150 1.24%
T. Rowe Price Associates, Inc. (Investment Management) 14,549,656 1.12%
Capital Research & Management Co. (International Investors) 13,751,442 1.06%
Holdings
NameEquities%Valuation
Galapagos (GLPG) 6,760,70112.4%622,607,626 USD
Allogene Therapeutics Inc (ALLO) 7,486,6896.16%201,616,535 USD
Agenus Inc (AGEN) 11,111,1119.26%26,444,444 USD
Markets and indexes
- Nasdaq Stock Market
- Nasdaq Global Select Market
- Nasdaq 100 / SP 100, SP 500, Stoxx Americas 100, Stoxx Global 200, Stoxx NorthAmerica 50
Stock Exchange Codes
- Bloomberg Code :  GILD:US
- Reuters Code :  GILD.O
- Datastream Code :  @GILD
Company contact information
Gilead Sciences
333 Lakeside Drive
CA 94404 San Mateo, California
États-Unis (les)

Phone : +1 650 574 3000
Fax : +1 650 578 9264
Internet : http://www.gilead.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Gilead Sciences
Connections : Gilead Sciences
The University of Alabama at Birmingham
American Society of Clinical Investigation
Stanford University
Primus Pharmaceuticals, Inc.
Boys & Girls Club of Oakland
Charles Schwab Family of Funds
Gilead Connecticut, Inc.
Conifer Health Solutions LLC
Gilead Sciences International Ltd.
Children's Discovery Museum
Partners In Health
Collidion, Inc. (California)
Kite Pharma, Inc.
Catholic Health Initiatives
UCSF Benioff Children's Hospital Oakland
The Aids Institute, Inc.
Gilead Sciences Ltd.
Gilead Sciences GmbH
Gilead Sciences Europe Ltd.
Venture Lending & Leasing, Inc.
Oxford BioTherapeutics Ltd.
Sacred Heart Schools Atherton
The Royal Australasian College of Physicians
FermaVir Pharmaceuticals, Inc.
Acuitus, Inc.
Alabama Drug Discovery Alliance
Xyleco, Inc.
Washington University School of Medicine
Ralph M. Parsons Foundation
Association of American Physicians
GN Hearing A/S
Catholic Health Association of the USA
Medicines for Malaria Venture
Morehouse School of Medicine
GN Audio A/S
California Institute of Technology
University of Southern California
Jet Propulsion Laboratory
ISI Life Sciences, Inc.
GN Netcom A/S
Venture Lending & Leasing II, Inc.
Bio Malter
Gilead Foundation